Finance

Lists
Why is QNRX down 4,82%?
Dive Deeper
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
US$4,15
-4,82%
(-0,21) 1D
13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
US$4,49
High
US$4,56
Low
US$4,15
Mkt. cap
19,94 ລ້ານ
Avg. vol.
100,58 ພັນ
Volume
26,40 ພັນ
52-wk high
US$23,50
52-wk low
US$3,25
EPS
US$-423,73
Beta
1,56
Shares outstanding
4,80 ລ້ານ
No. of employees
5
Open
US$4,49
High
US$4,56
Low
US$4,15
Mkt. cap
19,94 ລ້ານ
Avg. vol.
100,58 ພັນ
Volume
26,40 ພັນ
52-wk high
US$23,50
52-wk low
US$3,25
EPS
US$-423,73
Beta
1,56
Shares outstanding
4,80 ລ້ານ
No. of employees
5
News stories
From web sources and news partners
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees5
Founded1986
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to QNRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for QNRX in the last 3 months.
Highest
Current US$4,15
US$35,00 (+743,37%)
Average
US$22,25 (+436,14%)
Lowest
US$14,00 (+237,35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Initiated
US$14,00
+237,3%
10/12/2026
Thomas Flaten
Lake Street
Buy
Initiated
US$20,00
+381,9%
09/23/2026
Naz Rahman
Maxim Group
Buy
Reiterated
US$20,00
+381,9%
09/03/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
US$35,00
+743,4%
08/17/2026
Ashok Kumar
ThinkEquity
Buy
Initiated
US$12,00
+189,2%
06/15/2026
Dev Prasad
Lucid Capital
Buy
Initiated
US$30,00
+622,9%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,28 ລ້ານ
3,10 ລ້ານ
3,43 ລ້ານ
3,63 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 ລ້ານ
1,42 ລ້ານ
1,70 ລ້ານ
1,85 ລ້ານ
Operating expense
4,02 ລ້ານ
4,52 ລ້ານ
5,13 ລ້ານ
5,47 ລ້ານ
Total operating expenses
4,02 ລ້ານ
4,52 ລ້ານ
5,13 ລ້ານ
5,47 ລ້ານ
Operating income
-4,02 ລ້ານ
-4,52 ລ້ານ
-5,13 ລ້ານ
-5,47 ລ້ານ
Other non operating income
9,49 ພັນ
364,00
-13,30 ພັນ
1,58 ພັນ
EBT including unusual items
-3,95 ລ້ານ
-4,35 ລ້ານ
-5,00 ລ້ານ
-5,37 ລ້ານ
EBT excluding unusual items
-3,95 ລ້ານ
-4,35 ລ້ານ
-5,00 ລ້ານ
-5,37 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,95 ລ້ານ
-4,35 ລ້ານ
-5,00 ລ້ານ
-5,37 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-6,70
-
-1,77
-1,90
Interest and investment income
62,27 ພັນ
171,70 ພັນ
146,78 ພັນ
100,95 ພັນ
Interest expense
-
-
-
-
Net interest expenses
62,27 ພັນ
171,70 ພັນ
146,78 ພັນ
100,95 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,99 ລ້ານ
-4,50 ລ້ານ
-5,11 ລ້ານ
-5,45 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google